✦ LIBER ✦

Protons vs megavoltage xrays as boost therapy for patients with localized prostatic carcinoma

✍ Scribed by J.R. Duttenhaver; W.U. Shipley; T. Perrone; L.J. Verhey; J.E. Munzenrider; M. Goitien; G.R. Prout Jr; H.D. Suit

Publisher: Elsevier Science
Year: 1980
Tongue: English
Weight: 81 KB
Volume: 6
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(80)90533-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protons or megavoltage X-rays as boost t

Protons or megavoltage X-rays as boost therapy for patients irradiated for localized prostatic carcinoma an early phase I/II comparison

✍ J. A. Duttenhaver; W. U. Shipley; T. Perrone; L. J. Verhey; M. Goitein; J. E. Mu 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

Mitoxantrone in patients with prostate s

Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma

✍ Robert S. DiPaola; Eric S. Chenven; Weichung J. Shih; Yong Lin; Peter Amenta; Su 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB 👁 2 views

Long-term hormone therapy and radiation

Long-term hormone therapy and radiation is cost-effective for patients with locally advanced prostate carcinoma

✍ Andre Konski; Deborah Watkins-Bruner; Harmar Brereton; Steven Feigenberg; Gerald 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

Early results of a prospective study of

Early results of a prospective study of hormone therapy for patients with locally advanced prostate carcinoma

✍ Jackson E. Fowler Jr.; Steven A. Bigler; John M. Kolski; David T. Yee 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 3 views

## Background: Locally advanced prostate carcinoma is usually not curable with surgery or radiation therapy. primary hormone therapy is an alternative therapeutic option, but contemporary prospective studies of the outcomes of such therapy are not available. ## Methods: The authors conducted a pr

The impact of a delay in initiating radi

The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma

✍ Paul L. Nguyen; Richard Whittington; Sophia Koo; Delray Schultz; Kerri B. Cote; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

Assessment of outcome prediction models

Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy

✍ Anthony V. D'Amico; April Desjardin; Arnold Chung; Ming-Hui Chen; Delray Schultz 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

or neoadjuvant hormonal or radiation therapy were excluded. Akaike's Information Criterion (AIC) and Schwartz Bayesian Criterion (SBC) estimates, which are com-1 Joint Center for Radiation Therapy, Harvard parative measures, were calculated for each clinical staging system. Pairwise com-Medical Scho